Acute Myeloid Leukemia Beyond FLT3 and IDH: The Role of Non-Targetable Driver Mutations episode artwork

EPISODE · May 2, 2023 · 35 MIN

Acute Myeloid Leukemia Beyond FLT3 and IDH: The Role of Non-Targetable Driver Mutations

from Keeping Current CME

Do you understand the role of non-targetable driver mutations in the management of acute myeloid leukemia (AML)? Credit available for this activity expires: 5/1/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/991353?ecd=bdc_podcast_libsyn_mscpedu

Episode metadata supplied by the publisher feed · Published May 2, 2023

Embed this episode

NOW PLAYING

Acute Myeloid Leukemia Beyond FLT3 and IDH: The Role of Non-Targetable Driver Mutations

0:00 35:55

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Keeping Current CME?

This episode is 35 minutes long.

When was this Keeping Current CME episode published?

This episode was published on May 2, 2023.

Can I download this Keeping Current CME episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!